BC Partners, the UK private equity group, has agreed a €500m ($712m) deal to acquire two European medical diagnostics companies, which it plans to merge into a vehicle to consolidate the laboratory services market.

The deal – financed with about €200m of bank debt – is designed to harness the long-term demographic trend for an increasingly ageing population to spend more on healthcare.